Ridha Essra 4
4 · AVROBIO, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
AVROBIO, Inc.AVRO
Ridha Essra
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+75,000→ 75,000 totalExercise: $1.84Exp: 2032-02-01→ Common Stock (75,000 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+80,000→ 80,000 totalExercise: $1.84Exp: 2032-02-01→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.